198 related articles for article (PubMed ID: 21690088)
1. Retinoic acid-induced gene-I (RIG-I) associates with nucleotide-binding oligomerization domain-2 (NOD2) to negatively regulate inflammatory signaling.
Morosky SA; Zhu J; Mukherjee A; Sarkar SN; Coyne CB
J Biol Chem; 2011 Aug; 286(32):28574-83. PubMed ID: 21690088
[TBL] [Abstract][Full Text] [Related]
2. Mutual Regulation of NOD2 and RIG-I in Zebrafish Provides Insights into the Coordination between Innate Antibacterial and Antiviral Signaling Pathways.
Nie L; Xu XX; Xiang LX; Shao JZ; Chen J
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555019
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of domains of IPS-1 using an inducible oligomerization system.
Takamatsu S; Onoguchi K; Onomoto K; Narita R; Takahasi K; Ishidate F; Fujiwara TK; Yoneyama M; Kato H; Fujita T
PLoS One; 2013; 8(1):e53578. PubMed ID: 23308256
[TBL] [Abstract][Full Text] [Related]
4. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
Kvarnhammar AM; Petterson T; Cardell LO
Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
[TBL] [Abstract][Full Text] [Related]
5. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
[TBL] [Abstract][Full Text] [Related]
6. The NOD2-RICK complex signals from the plasma membrane.
Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
[TBL] [Abstract][Full Text] [Related]
7. The complement C1qA enhances retinoic acid-inducible gene-I-mediated immune signalling.
Wang Y; Tong X; Zhang J; Ye X
Immunology; 2012 May; 136(1):78-85. PubMed ID: 22260551
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of RIG-I positively regulates the type I interferon signaling.
Mi Z; Fu J; Xiong Y; Tang H
Protein Cell; 2010 Mar; 1(3):275-83. PubMed ID: 21203974
[TBL] [Abstract][Full Text] [Related]
9. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.
Coutermarsh-Ott S; Eden K; Allen IC
J Gen Virol; 2016 Apr; 97(4):825-838. PubMed ID: 26763980
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells.
Vissers M; Remijn T; Oosting M; de Jong DJ; Diavatopoulos DA; Hermans PW; Ferwerda G
Eur J Immunol; 2012 Oct; 42(10):2727-35. PubMed ID: 22730064
[TBL] [Abstract][Full Text] [Related]
11. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction.
Gack MU; Kirchhofer A; Shin YC; Inn KS; Liang C; Cui S; Myong S; Ha T; Hopfner KP; Jung JU
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16743-8. PubMed ID: 18948594
[TBL] [Abstract][Full Text] [Related]
12. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.
Marinis JM; Homer CR; McDonald C; Abbott DW
J Biol Chem; 2011 Jan; 286(3):1938-50. PubMed ID: 21097508
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis.
Nabatov AA; Hatzis P; Rouschop KM; van Diest P; Vooijs M
Biochim Biophys Acta; 2013 Nov; 1830(11):5277-86. PubMed ID: 23880069
[TBL] [Abstract][Full Text] [Related]
14. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
[TBL] [Abstract][Full Text] [Related]
16. Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.
Kapoor A; Forman M; Arav-Boger R
PLoS One; 2014; 9(3):e92704. PubMed ID: 24671169
[TBL] [Abstract][Full Text] [Related]
17. The catcher in the RIG-I.
Weber F
Cytokine; 2015 Nov; 76(1):38-41. PubMed ID: 26168692
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of melanoma differentiation-associated gene 5 (MDA5)-dependent antiviral innate immune responses by Arf-like protein 5B.
Kitai Y; Takeuchi O; Kawasaki T; Ori D; Sueyoshi T; Murase M; Akira S; Kawai T
J Biol Chem; 2015 Jan; 290(2):1269-80. PubMed ID: 25451939
[TBL] [Abstract][Full Text] [Related]
19. ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner.
Yang YK; Qu H; Gao D; Di W; Chen HW; Guo X; Zhai ZH; Chen DY
J Biol Chem; 2011 Mar; 286(12):10568-80. PubMed ID: 21233210
[TBL] [Abstract][Full Text] [Related]
20. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
